BioAge Labs Shares Surge on Nasdaq Debut

MT Newswires Live09-27

BioAge Labs (BIOA) shares were up almost 28% in recent trading Thursday after debuting on Nasdaq, higher than the initial public offering price of $18 per share.

The stock is trading under the ticker symbol "BIOA."

The company is offering 11 million shares in the IPO for gross proceeds of $198 million and has granted underwriters an overallotment option of additional 1.7 million shares.

Price: 23.01, Change: +5.01, Percent Change: +27.83

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment